A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients

Clinical trial NCT01631825 · COMPLETED

Trial details

NCT number: NCT01631825
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2009-10-01
Primary completion: 2012-06-01
Enrollment: 321

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.